Genetic Studies of Atherosclerosis Risk | NHLBI Trans-Omics for Precision Medicine Skip to main content

Genetic Studies of Atherosclerosis Risk

Short Name
GeneSTAR
Institution(s)
Johns Hopkins University
Type of Omics
WGS
Approx. Sample Size 1400
Disease/Phenotype
Platelet aggregation, Premature coronary artery disease, Extensive coagulation traits, Aspirin intervention
Starting Phase
Phase 2
TOPMed Accession #
phs001218
Omics Center(s) Phase 2
Psomagen
Specify the TOPMed Phase for the Omics Center(s) selected above
legacy
Phases Involved
2
Populations
African American families, European families
PI
Contact
NIH Program Officer
Phenotype Liaison
Data Set contact(s)
Project
GeneSTAR
Back to top